The Rangers are the defending World Series champions but they currently sport a record of 46-50 that has them 7.5 games back of a Wild Card spot. They’re five games out in the AL West, where they trail the Mariners and Astros. With less than two weeks until the trade deadline, general manager Chris Young will have some decisions to make but is currently hoping his players make the decision for him.
“We are going to do everything we can to win this year,” Young tells Joel Sherman of The New York Post, though he also left some ambiguity by adding that he “wants to take as much time as possible to make a choice and hope in the next week [the results] make it clear we are buyers.”
The Playoff Odds at FanGraphs currently give them a 12.3% chance at cracking the postseason while the PECOTA Standings at Baseball Prospectus are slightly more optimistic at 18.2%. Young and his staff will presumably be discussing all kinds of trade scenarios with other clubs in the coming days, as the Rangers host the Orioles for three games, the White Sox for four and then cross the northern border to play three in Toronto. They will then start a three-game set in St. Louis but the deadline will be on July 30, after just one game against the Cardinals.
It’s an interesting spot for Young and the Rangers to be in, with potential arguments for buying, selling or some kind of combination. The argument in favor of buying would largely hinge on the club having much better health in the second half than in the first.
On the position player side, both Evan Carter and Josh Jung are currently on the injured list. Carter struggled over the first two months of the season, hitting just .188/.272/.361 while battling back tightness that eventually put him on the shelf. Manager Bruce Bochy later described it as a stress reaction, per Shawn McFarland of The Dallas Morning News, with the timeline still unclear. Jung has only played four games this year before being hit by a pitch and suffering a wrist fracture that required surgery. His rehab assignment was shut down a few weeks ago due to continued discomfort and his ramp-up is also somewhat murky.
On the pitching side, Andrew Heaney has been the only consistent rotation member. Each of Nathan Eovaldi, Michael Lorenzen and Jon Gray spent some time on the injured list, though each is currently active. Max Scherzer had offseason back surgery and began the season on the IL, then had his return delayed by a thumb injury. He has missed most of this season so far but returned in recent weeks and has taken the ball five times this year.
The rotation could be getting further reinforcements, with both Jacob deGrom and Tyler Mahle working back from Tommy John surgeries they underwent last summer. Dane Dunning and Cody Bradford are also on the IL and could return later in the year.
That theoretically stronger rotation and the possible returns of Carter and/or Jung could perhaps inspire the club to push hard at the deadline, hoping to gain steam for a strong second half. But it could also be an argument for doing some selling. Hypothetically, if everyone were to be healthy at some point in the coming months, the club would have nine rotation candidates in deGrom, Scherzer, Eovaldi, Gray, Mahle, Heaney, Lorenzen, Bradford and Dunning.
The club probably doesn’t want to bank on all of them being healthy at the same time, so they wouldn’t necessarily need to trim the number to five. Dunning has often pitched in relief and can be kept there. Bradford has a 1.40 ERA this year but in a small sample of three starts. Despite the strong results, the Rangers would be justified in optioning him to the minors if he were blocked by their more established guys.
But that still leaves seven solid veteran options that could all be healthy in the weeks to come. Perhaps the club will feel they could trade an impending free agent or two without really “selling” here in 2024 or hurting themselves too much in the future, something that MLBTR’s Steve Adams recently took a look at in a piece for Front Office subscribers. Lorenzen is on a one-year deal and set to return to the open market at season’s end. Heaney is in the final season of his two-year deal.
Scherzer is also slated for free agency at season’s end but has a full no-trade clause. He was recently asked on Foul Territory about waiving it again, as he did to come to the Rangers from the Mets, with that show relaying video on X. Scherzer said “I’m not gonna do that” before elaborating that he thought the club would play better and make it a moot point.
Eovaldi is in the final guaranteed year of his deal though there’s a vesting player option for 2025 he could potentially unlock. There were three ways for him to unlock that player option, though one of them involved making the 2024 All-Star team. Since he wasn’t chosen, he’s down to two paths. His best chance is to get to 300 combined innings pitched over 2023 and 2024. He’s currently at 238 and therefore 62 shy of the line, which he should be able to cross if he stays healthy the rest of the year. His other path to unlocking the player option is to finish in the top five in Cy Young voting. That option muddies any trade the Rangers might consider and he has limited trade protection on his deal as well.
Gray and Mahle each have one year left of their deals, making them at least somewhat plausible trade candidates, though moving them would hurt the club’s chances next year. With Scherzer, Heaney and Lorenzen slated for free agency after 2024, the Rangers might want to keep Gray and Mahle in the mix for 2025 alongside deGrom, Bradford, Dunning and maybe Eovaldi.
If the Rangers end up more firmly in the seller camp, they would have those aforementioned pitchers to market, as well as impending free agents David Robertson, José Leclerc, Kirby Yates, José Ureña, Travis Jankowski and Robbie Grossman. Based on Young’s comments, it sounds like it would take a rough performance in the coming weeks for them to sell, but those would be the options. Sherman also floats the possibility of Adolis García or Nathaniel Lowe being available, though each is arbitration controlled through 2026 and it doesn’t seem as though something that drastic is on the table, though it could always come about if some club comes in with an offer that can’t be refused.
Like many other clubs around the league, the Rangers are set for a pseudo postseason push in the weeks to come. With the buyer and seller paths both seemingly on the table, the Texas season will be on the line in the coming weeks, at least to an extent. As Young and his crew have to decide how hard to push in one direction or the other, the upcoming part of the schedule could perhaps define the team for the months that follow.
